Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Planned global Phase 3 LEGACY trial of tegoprubart in kidney transplantation remains on track to ini
Planned global Phase 3 LEGACY trial of tegoprubart in kidney transplantation remains on track to ini